|
Delayed
Nasdaq Tallinn
16:30:00 18/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 19.00 EUR | -0.52% |
|
-2.06% | -32.14% |
| 1 day | -0.52% | ||
| 1 week | -2.06% | ||
| Current month | -1.04% | ||
| 1 month | -4.52% | ||
| 3 months | -19.49% | ||
| 6 months | -26.36% | ||
| Current year | -32.14% |
| 1 week | 19 |  | 19.2 |
| 1 month | 19 | | 19.6 |
| Current year | 19 | | 28 |
| 1 year | 15 | | 30.8 |
| 3 years | 9.64 | | 32.6 |
| 5 years | 5 | | 32.6 |
| 10 years | 5 | | 32.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 52 | 01/01/2015 | |
Liina Kervemann
DFI | Director of Finance/CFO | - | - |
Erik Berlin
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Martin Wilson
BRD | Director/Board Member | 49 | - |
Karita Sall
BRD | Director/Board Member | 52 | - |
Yoann John Ricau
BRD | Director/Board Member | 51 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | -2.06% | -34.48% | +91.92% | 37.34M | |
| -0.04% | -1.67% | +16.32% | +67.02% | 47.69B | |
| +4.52% | +1.33% | +56.08% | +133.25% | 39.96B | |
| +0.81% | -1.75% | -7.30% | +16.17% | 12.02B | |
| +1.09% | -4.37% | +13.53% | +70.92% | 11.53B | |
| 0.00% | +0.19% | +30.00% | +147.62% | 9.18B | |
| -0.39% | -1.15% | +19.93% | +39.54% | 7.53B | |
| +0.87% | +2.65% | +46.27% | -10.72% | 7.29B | |
| +3.08% | -0.25% | +20.28% | +198.57% | 6.63B | |
| -3.28% | -4.68% | -33.43% | +20.83% | 5.57B | |
| Average | +0.61% | -2.38% | +12.72% | +77.51% | 14.74B | |
| Weighted average by Cap. | +1.40% | -2.32% | +25.76% | +85.08% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | €19.00 | -0.52% | 5 |
| 17/08/26 | €19.10 | -0.52% | 3 |
| 13/08/26 | €19.20 | -1.03% | 4 |
| 12/08/26 | €19.40 | 0.00% | 2 |
- Stock Market
- Stocks
- MOLNRIPO Stock
Select your edition
All financial news and data tailored to specific country editions
